title: Managing non-alcoholic fatty liver disease in diabetes: Challenges and opportunities.
authors.affiliation: Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong City, Hong Kong.
authors.forename: Chi-Ho
authors.initials: CH
authors.lastname: Lee
authors.affiliation: Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong City, Hong Kong.|Research Center of Heart, Brain, Hormone and Healthy Aging, University of Hong Kong, Hong Kong City, Hong Kong.
authors.forename: Karen Siu-Ling
authors.initials: KS
authors.lastname: Lam
mesh_terms: D000328:Adult; D015415:Biomarkers / Q000032:analysis; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000453:epidemiology / Q000628:therapy*; D006801:Humans; D065626:Non-alcoholic Fatty Liver Disease / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D009765:Obesity / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology; D017410:Practice Guidelines as Topic / Q000592:standards; D010818:Practice Patterns, Physicians' / Q000592:standards / Q000639:trends; D018160:Receptors, Cytoplasmic and Nuclear / Q000378:metabolism; D035703:Therapies, Investigational / Q000379:methods / Q000639:trends; D045162:Thiazolidinediones / Q000627:therapeutic use; D000097789:Glucagon-Like Peptide-1 Receptor Agonists; D000099150:Receptor, Farnesoid X-Activated; D000067757:Glucagon-Like Peptide-1 Receptor
chemical_list: D015415:Biomarkers; D018160:Receptors, Cytoplasmic and Nuclear; D045162:Thiazolidinediones; D000097789:Glucagon-Like Peptide-1 Receptor Agonists; D000099150:Receptor, Farnesoid X-Activated; C000593833:GLP1R protein, human; D000067757:Glucagon-Like Peptide-1 Receptor